Increased pancreatic islet mass is accompanied by activation of the insulin receptor substrate-2/serine-threonine kinase pathway and augmented cyclin D2 protein levels in insulin-resistant rats

International Journal of Experimental Pathology

Volumn 89, Issue 4, 2008, Pages 264-275

  Rafacho, Alex ^a,c   Ribeiro, Daniele Lisboa ^a   Boschero, Antonio Carlos ^a   Taboga, Sebastião Roberto ^b   Bosqueiro, José Roberto ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c IB   (Brazil)

Author keywords

Cell cycle proteins; Glucocorticoid; Insulin resistance; Pancreatic islet; Structure; Ultrastructure

Indexed keywords

CYCLIN D2; CYCLINE; DEXAMETHASONE; INSULIN RECEPTOR SUBSTRATE 2; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; RETINOBLASTOMA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; GOLGI COMPLEX; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; MALE; MITOSIS; NONHUMAN; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL; RAT; ULTRASTRUCTURE;

EID: 47649101647     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2008.00588.x     Document Type: Article

References (61)

1. Alonso L.C., Yokoe T., Zhang P. et al. (2007) Glucose infusion in mice. A new model to induce β-cell replication. Diabetes 56, 1792 1801.
2. Amaral M.E., Cunha D.A., Anhê G.F. et al. (2004) Participation of prolactin receptors and phosphatidylinositol 3-kinase and MAP kinase pathways in the increase in pancreatic islet mass and sensitivity to glucose during pregnancy. J. Endocrinol. 183, 469 476.
3. Anderson J.W., Kendall C.W., Jenkins D.J. (2003) Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J. Am. Coll. Nutr. 22, 331 339.
4. Araki E., Lipes M.A., Patti M.E. et al. (1994) Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372, 186 190.
5. Barbera M., Fierabracci V., Novelli M. et al. (2001) Dexamethasone- induced insulin resistance and pancreatic adaptive response in aging rats are not modified by oral vanadyl sulfate treatment. Eur. J. Endocrinol. 145, 799 806.
6. Beard J.C., Halter J.B., Best J.D., Pfeifer M.A., Porte D. Jr. (1984) Dexamethasone-induced insulin resistance enhances B cell responsiveness to glucose level in normal men. Am. J. Physiol. 247, E592 E596.
7. Bonner-Weir S. (2000) Life and death of the pancreatic beta cells. Trends Endocrinol. Metab. 11, 375 378.
8. Bonner-Weir S. (2001) Beta-cell turnover: its assessment and implications. Diabetes 50, S20 S24.
9. Bonner-Weir S., Trent D.F., Zmachinski C.J., Clore E.T., Weir G.C. (1981) Limited B cell regeneration in a B cell deficient rat model: studies with dexamethasone. Metabolism 9, 914 918.
10. Boquist L. (1972) Obesity and pancreatic islet hyperplasia in the Mongolian gerbil. Diabetologia 8, 274 282.
11. Bruning J.C., Winnay J., Bonner-Weir S., Taylor S.I., Accili D., Kahn C.R. (1997) Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88, 561 572.
12. Burén J., Liu H.X., Jensen J., Eriksson J.W. (2002) Dexamethasone impairs insulin signaling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes. Eur. J. Endocrinol. 146, 419 429.
13. Cotta-Pereira G., Rodrigo F.G., David-Ferreira J.F. (1976) The use of tannic acid-glutaraldehyde in the study of elastic related fibers. Stain Technol. 51, 7 11.
14. 1. Diabetes 53, 149 159.
15. De Carvalho H.F., Lino Neto J., Taboga S.R. (1994) Microfibrils: neglected components of pressure-bearing tendons. Ann. Anat. 176, 155 159.
16. Diani A.R., Sawada G.A., Hannah B.A. et al. (1987) Analysis of pancreatic islet cells and hormone content in the spontaneously diabetic KKAy mouse by morphometry, immunocytochemistry and radioimmunoassay. Virch. Arch. A. Pathol. Anat. Histopathol. 412, 53 61.
17. Fatrai S., Elghazi L., Balcazar N. et al. (2006) AKT induces beta-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. Diabetes 55, 318 325.
18. Fernández E., Angeles Mártin M., Fajardo S., Escrivá F., Álvarez C. (2006) Increased IRS-2 content and activation of IGF-1 pathway contribute to enhance B-cell mass in fetuses from undernourished pregnant rats. Am. J. Physiol. Endocrinol. Metab. 292, E187 E195.
19. Friedrichsen B.N., Neubauer N., Lee Y.C. et al. (2006) Stimulation of pancreatic β-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways. J. Endocrinol. 188, 481 492.
20. Garcia-Ocaña A., Takane K., Syed M.A., Phlibrick W.M., Vasavada R.C., Stewart A.F. (2000) Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass and induces mild hypoglycemia. J. Biol. Chem. 275, 1226 1232.
21. Gómez Dumm C.L.A., Cónsole M., Luna G.C., Dardene M., Goya R.G. (1995) Quantitative immunohistochemical changes in the endocrine pancreas of nonobese diabetic (NOD) mice. Pancreas 11, 396 401.
22. Heit J.J., Karnik S.K., Kim S.K. (2006) Intrinsic regulators of pancreatic β-cell proliferation. Ann. Rev. Cell. Dev. Biol. 22, 311 338.
23. Holness M.J., Smith N.D., Greenwood G.K., Sugden M.C. (2005) Interactive influences of peroxisome proliferator-activated receptor α activation and glucocorticoids on pancreatic beta cell compensation in insulin resistance induced by dietary saturated fat in the rat. Diabetologia 48, 2062 2068.
24. Hoogwerf B. Danese R.D. (1999) Drug selection and the management of corticosteroid-related diabetes mellitus. Rheum. Dis. Clin. North Am. 25, 489 505.
25. Janssen S.W., Hermus A.R., Lange W.P. et al. (2001) Progressive histopathological changes in the pancreatic islets during aging of Zucker diabetic fatty rats. Exp. Clin. Endocrinol. Diabetes 109, 273 282.
26. Janssen S.W., Martens G.J., Sweep C.G., Span P.N., Verhofstad A.A., Hermus A.R. (2003) Phlorizin treatment prevents the decrease in plasma insulin levels but not the progressive histopathological changes in the pancreatic islets during age of Zucker diabetic fatty rats. J. Endocrinol. Invest. 26, 508 515.
27. Jonas L., Putzke H.P., Hahn von Dorsche H. (1983) Islands of Langerhans of rats (Rattus norvegicus, Forma alba) after high prednisolone dosage - a semiquantitative light and electron microscopic study. Anat. Anz. 154, 273 282.
28. Kido Y., Burks D.J., Withers D. et al. (2000) Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J. Clin. Invest. 105, 199 205.
29. Kushner J.A., Ye J., Schubert M. et al. (2002) Pdx1 restores β cell function in Irs2 knockout mice. J. Clin. Invest. 109, 1193 1201.
30. Lingohr M.K., Dickson L.M., McCuaig J.F., Hugl S.R., Twardzik D.R., Rhodes C.J. (2002) Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation. Diabetes 51, 966 976.
31. Lipsett M.A., Austin E.B., Castellarin M.L., Lemay J., Rosenberg L. (2006) Evidence for the homeostatic regulation of induced beta cell mass expansion. Diabetologia 49, 2910 2919.
32. Mello M.L.S. (1997) Cytochemistry of DNA, RNA and nuclear proteins. Braz. J. Genet. 20, 257 264.
33. Momose K., Nunomiya S., Nakata M., Yada T., Kikuchi M., Yashiro T. (2006) Immunohistochemical and electron-microscopic observation of B-cells in pancreatic islets of spontaneously diabetic Goto-Kakizaki rats. Med. Mol. Morphol. 39, 146 153.
34. Muller D., Jones P.M., Persaud S.J. (2006) Autocrine anti-apoptotic and proliferative effects of insulin in pancreatic b-cells. FEBS Lett. 580, 6977 6980.
35. Nicod N., Giusti V., Besse C., Tappy L. (2003) Metabolic adaptations to dexamethasone-induced insulin resistance in healthy volunteers. Obes. Res. 11, 625 631.
36. Niessen A. (2006) On the role of IRS2 in the regulation of functional ß-cell mass. Arch. Physiol. Biochem. 112, 65 73.
37. Novelli M., De Tata V., Bombara M. et al. (1999) Insufficient adaptive capability of pancreatic endocrine function in dexamethasone-treated ageing rats. J. Endocrinol. 162, 425 432.
38. Ogawa A., Johnson J.H., Ohneda M. et al. (1992) Roles of insulin resistance and ß-cell dysfunction in dexamethasone-induced diabetes. J. Clin. Invest. 90, 497 504.
39. Okada T., Liew C.W., Hu J. et al. (2007) Insulin receptors in β-cells are critical for islet compensatory growth response to insulin resistance. Proc. Natl Acad. Sci. USA 104, 8977 8982.
40. Pagano G., Cavallo-Perin P., Cassader M. et al. (1983) An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J. Clin. Invest. 72, 1814 1820.
41. Paris M., Bernard-Kargar C., Berthault M.F., Bouwens L., Ktorza A. (2003) Specific and combined effects of insulin and glucose on functional pancreatic β-cell mass in vivo in adult rats. Endocrinology 144, 2717 2727.
42. Pick A., Clark J., Kubstrup C. et al. (1998) Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat. Diabetes 47, 358 364.
43. Rafacho A., Roma L.P., Taboga S.R., Boschero A.C., Bosqueiro J.R. (2007) Dexamethasone-induced insulin resistance is associated with increased connexins 36 mRNA and protein expression in pancreatic rat islets. Can. J. Physiol. Pharmacol. 53, 881 885.
44. Rafacho A., Giozzet V.A.G., Boschero A.C., Bosqueiro J.R. (2008) Functional alterations in endocrine pancreas of rats with different degrees of dexamethasone-induced insulin resistance. Pancreas 36, 284 293.
45. Ruzzin J., Wagman A.S., Jensen J. (2005) Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signaling and the effects of a selective glycogen synthase kinase-3 inhibitor. Diabetologia 48, 2119 2130.
46. Saad M.J., Folli F., Kahn J.A., Kahn C.R. (1993) Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. J. Clin. Invest. 92, 2065 2072.
47. Scott A.M., Atwater I., Rojas E. (1981) A method for the simultaneous measurement of insulin release and B cell membrane potential in single mouse islets of Langerhans. Diabetologia 21, 470 475.
48. Severino C., Brizzi P., Solinas A., Secchi G., Maioli M., Tonolo G. (2002) Low-dose dexamethasone in the rat. A model to study insulin resistance. Am. J. Physiol. 283, E367 E373.
49. Spencer A.J., Andreu M., Greaves P. (1986) Neoplasia and hyperplasia of pancreatic endocrine tissue in the rat: an immunocytochemical study. Vet. Pathol. 23, 11 15.
50. Tamemoto H., Kadowaki T., Tobe K. et al. (1994) Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372, 182 186.
51. Terauchi I., Takamoto I., Kubota N. et al. (2007) Glucokinase and IRS-2 are required for compensatory B cell hyperplasia in response to high-fat diet-induced insulin resistance. J. Clin. Invest. 117, 246 257.
52. Tomita T., Visser P., Friesen S., Doull V. (1984) Cortisone-induced islet cell hyperplasia in hamsters. Virch. Arch. B Cell Pathol. Incl. Mol. Pathol. 45, 85 95.
53. Vasavada R.C., Gonzáles-Pertusa J.A., Fujinaka I., Fiaschi-Taesch N., Cozar-Castellano I., Garcia-Ocaña A. (2006) Growth factors and beta cell replication. Int. J. Biochem. Cell Biol. 38, 931 950.
54. Vasavada R.C., Cozar-Castellano I., Sipula D., Stewart A.F. (2007) Tissue-specific deletion of the retinoblastoma protein in the pancreatic B-cell has limited effects on B-cell replication, mass, and function. Diabetes 56, 57 64.
55. Villanueva-Peñacarrillo M.L., Cancelas J., de Miguel F. et al. (1999) Parathyroid hormone-related peptide stimulates DNA synthesis and insulin secretion in pancreatic islets. J. Endocrinol. 163, 403 408.
56. Visser P.A., Pierce G.E., Tomita T., Friesen S.R. (1979) Stimulation of pancreatic islet hypertrophy and beta-cell hyperplasia in Syrian hamsters. Surg. Forum 30, 310 311.
57. Weibel E.R. (1972) The value of stereology in analysing structure and function of cells and organs. J. Microsc. 95, 3 13.
58. Weir G.C., Laybutt D.R., Kaneto H., Bonner-Weir S., Sharma A. (2001) Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes 50, S154 S159.
59. Withers D.J., Gutierrez J.S., Towery H., Burks D.J., Ren J.M. et al. (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900 904.
60. Zhang X., Gaspard J.P., Mizukami Y., Li J., Graeme-Cook F., Chung D.C. (2005) Overexpression of cyclin D1 in pancreatic beta-cells in vivo results in islet hyperplasia without hypoglycemia. Diabetes 54, 712 719.
61. Zwicker G.M. Eyster R.C. (1993) Chronic effects of corticosteroid oral treatment in rats on blood glucose and serum insulin levels, pancreatic islet morphology, and immunostaining characteristics. Toxicol. Pathol. 21, 502 508.